Cargando…

α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease

Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer’s disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an impor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toyohara, Jun, Hashimoto, Kenji
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023065/ https://www.ncbi.nlm.nih.gov/pubmed/21249164 http://dx.doi.org/10.2174/1874104501004010037

Ejemplares similares

In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [(11)C]A-582941 and [(11)C]A-844606 in Mice and Conscious Monkeys
por: Toyohara, Jun, et al.
Publicado: (2010)

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
por: Keefe, Richard SE, et al.
Publicado: (2015)

Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
por: Hashimoto, Kenji
Publicado: (2015)

α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 Ameliorates Cognitive Impairment Induced by Chronic Intermittent Hypoxia
por: Shen, Hui, et al.
Publicado: (2021)

Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases
por: Foucault-Fruchard, Laura, et al.
Publicado: (2017)

Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects
por: Ishikawa, Masatomo, et al.
Publicado: (2011)

S232. ALPHA7 NICOTINIC RECEPTOR AGONISTS REVERSE THE HYPERDOPAMINERGIC STATE IN THE MAM MODEL OF SCHIZOPHRENIA
por: Neves, Gilda, et al.
Publicado: (2018)

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
por: Bristow, Linda J., et al.
Publicado: (2016)

Brain Imaging of Nicotinic Receptors in Alzheimer's Disease
por: Wu, Jin, et al.
Publicado: (2010)

Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms
por: Recio-Barbero, María, et al.
Publicado: (2021)

Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages
por: Tan, Yao, et al.
Publicado: (2022)

Effects of an Alpha7 Nicotinic Receptor Agonist and Stress on Spatial Memory in an Animal Model of Alzheimer's Disease
por: Vicens, Paloma, et al.
Publicado: (2013)

Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking
por: Bakanidze, George, et al.
Publicado: (2013)

Differential Modulation of GABA(A) and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
por: Zhou, Xujiao, et al.
Publicado: (2017)

Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors
por: Gill, JasKiran K., et al.
Publicado: (2013)

Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective
por: Neumann, Silke, et al.
Publicado: (2015)

Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease
por: Furuse, Tsutomu, et al.
Publicado: (2010)

A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE
por: Godin, Jean-Rémi, et al.
Publicado: (2019)

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Analogs of 6-Bromohypaphorine with Increased Agonist Potency for α7 Nicotinic Receptor as Anti-Inflammatory Analgesic Agents
por: Ivanov, Igor A., et al.
Publicado: (2023)

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia
por: Sabri, Osama, et al.
Publicado: (2018)

Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
por: Fonar, Gennadiy, et al.
Publicado: (2021)

Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders
por: Lee, Chien-Hsing, et al.
Publicado: (2022)

Potentiation of cognitive enhancer effects of Alzheimer’s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task
por: Bruszt, Nóra, et al.
Publicado: (2021)

Different Characteristics of Cognitive Impairment in Elderly Schizophrenia and Alzheimer's Disease in the Mild Cognitive Impairment Stage
por: Kazui, Hiroaki, et al.
Publicado: (2011)

The selective α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced inflammation and lung injury
por: Kox, M, et al.
Publicado: (2009)

Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor
por: Spurny, Radovan, et al.
Publicado: (2015)

6-Bromohypaphorine from Marine Nudibranch Mollusk Hermissenda crassicornis is an Agonist of Human α7 Nicotinic Acetylcholine Receptor
por: Kasheverov, Igor E., et al.
Publicado: (2015)

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020)

Upregulation of astrocytic α7 nicotinic receptors in Alzheimer's disease brain- possible relevant to amyloid pathology
por: Yu, Wenfeng, et al.
Publicado: (2012)

Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse
por: Vohora, Divya, et al.
Publicado: (2012)

Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia
por: Brunzell, Darlene H, et al.
Publicado: (2012)

Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens
por: Zhang, Ji-chun, et al.
Publicado: (2016)

Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors
por: Richter, K., et al.
Publicado: (2016)

Effects of splenectomy and GTS-21, a selective α7 nicotinic acetylcholine receptor agonist, on the development of septic ileus in mice
por: Nullens, S, et al.
Publicado: (2014)

Trace Eyeblink Conditioning is Impaired in α7 but not in β2 Nicotinic Acetylcholine Receptor Knockout Mice
por: Brown, Kevin L., et al.
Publicado: (2010)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

Menthol Binding and Inhibition of α7-Nicotinic Acetylcholine Receptors
por: Ashoor, Abrar, et al.
Publicado: (2013)

Mechanism of calcium potentiation of the α7 nicotinic acetylcholine receptor
por: Natarajan, Kathiresan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6d01u2r3uomspecgip5tmej7ak